Skip To Content
Search
When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with swipe gestures.
Type
All
AllStoriesVideoAudioGraphicsBusinessweek
Sort
By Newest
By NewestBy RelevanceBy Oldest
Time
Any Time
Any TimeLast 24 HoursPast WeekPast Month

Showing results for "Sartorius Stedim"

relates to Warburg Pincus Hands Cash Back to Investors as Rivals Struggle
wealth
Warburg Pincus Hands Cash Back to Investors as Rivals Struggle
By Gillian Tan
The largest US private equity firms have disappointed some fund investors with dwindling distributions in the past two years as they struggled to exit investments.
February 22, 2024
relates to Sartorius Sunk by Short-Sellers as Profit Declines
opinion
Sartorius Sunk by Short-Sellers as Profit Declines
By Chris Bryant
Sartorius’ sales have proven to be far more volatile than investors figured.
October 19, 2023
relates to Sartorius Plunges as Covid Lab Equipment Provider Cuts Forecasts
markets
Sartorius Plunges as Covid Lab Equipment Provider Cuts Forecasts
By Thomas Mulier
Sartorius AG shares plunged after the German maker of lab equipment for drugmakers cut its earnings forecast as demand weakens following the Covid-19 pandemic.
June 19, 2023
relates to Stock Markets Today: Macron's Ukraine plan, Beige Book, Tesla prices, Instagram
markets
Stock Markets Today: Macron's Ukraine plan, Beige Book, Tesla prices, Instagram
By Tassia Sipahutar
Get up to speed with what the markets are monitoring
April 20, 2023
relates to Sartorius to Buy DNA Research Supplier Polyplus for $2.6 Billion
business
Sartorius to Buy DNA Research Supplier Polyplus for $2.6 Billion
By Eric Pfanner
Sartorius Stedim Biotech agreed to buy Polyplus, a maker of transfection reagents for gene research, for about 2.4 billion euros ($2.6 billion) from a group of private investors.
March 31, 2023
relates to A 35,000% Stock Market Return in Europe? Here's What You Missed
opinion
A 35,000% Stock Market Return in Europe? Here's What You Missed
By Chris Bryant
Orks, animal semen and stock market voodoo lead to the holy grail of investing.
December 19, 2022
relates to These Are the Stocks to Watch as Covid Enters Its Next Phase
markets
These Are the Stocks to Watch as Covid Enters Its Next Phase
By Abhishek Vishnoi and Cristin Flanagan
The first pill to treat Covid-19 is on its way and vaccine producers are rolling out booster shots in wealthy countries. For investors, the next stage of the pandemic means a tougher landscape for stockpicking.
October 8, 2021
relates to Bargain Frenzy Give $1.7 Trillion Lift to Europe’s Stock Market
markets
Bargain Frenzy Give $1.7 Trillion Lift to Europe’s Stock Market
By Michael Msika and Kit Rees
In a record-breaking month that added $1.7 trillion to European equities, none rallied as hard as unloved bargain stocks.
November 28, 2020
relates to Will Europe’s First-Half Stock Winners Keep Surging in Second?
markets
Will Europe’s First-Half Stock Winners Keep Surging in Second?
By Kit Rees, Morwenna Coniam, and Katharine Gemmell
June 27, 2020
relates to PSA Sees Car Sales Slump, BHP Warns on Infections: Earnings Wrap
technology
PSA Sees Car Sales Slump, BHP Warns on Infections: Earnings Wrap
By Sam Unsted
French automaker PSA Group forecast the European car market will shrink by a quarter this year because of the coronavirus pandemic, while mining giant BHP Group warned that a second wave of infections could derail the recovery in China’s steel industry and Danone withdrew its guidance as the pandemic takes a toll on bottled-water sales.
April 21, 2020